The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMid Wynd International Investment Trust Regulatory News (MWY)

Share Price Information for Mid Wynd International Investment Trust (MWY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 764.00
Bid: 762.00
Ask: 764.00
Change: 4.00 (0.53%)
Spread: 2.00 (0.262%)
Open: 766.00
High: 766.00
Low: 757.00
Prev. Close: 760.00
MWY Live PriceLast checked at -
Mid Wynd International is an Investment Trust

To achieve capital and income growth by investing in companies on a worldwide basis.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV and revised Initial Placing and Offers Price

6 Jun 2017 17:16

RNS Number : 3386H
Mid Wynd Inter Inv Trust PLC
06 June 2017
 

To: RNS

From: Mid Wynd International Investment Trust PLC

Date: 6 June 2017

 

Mid Wynd International Investment Trust PLC

Miscalculation of Net Asset Value

The Company has identified that, since the interim dividend ex date on 25 May 2017, the interim dividend of 2.92 pence per Ordinary Share has not been accrued in the Net Asset Value as it should have been and the Net Asset Value per Ordinary Share has therefore been misstated.

This has now been corrected and as at close of business on 5 June 2017 the Net Asset Value per Ordinary Share was:

Net Asset Value per Ordinary Share

excluding current year income

443.63p

 

including current year income

443.78p

Issue of New Shares

Based on the revised Net Asset Value per Ordinary Share as at 30 May 2017 the issue price of the New Shares issued under the Initial Placing and Offers (being a 2 per cent. premium to the Net Asset Value per Ordinary Share as at 30 May 2017) as announced on 31 May 2017 should have been 448.51 pence per New Share (the original issue price was calculated at 451.49 pence). The Company is therefore arranging for additional New Shares to be issued to investors who received New Shares in the Initial Placing and Offers in order to reflect this. Application has therefore been made for 8,435 New Shares to be admitted to the Official List and to trading on the London Stock Exchange's Main Market for listed securities ("Admission"). It is expected that Admission will become effective and dealings in such New Shares will commence on 9 June 2017.

Following Admission the Company expects to have 32,531,416 Ordinary Shares in issue. The total number of voting rights of the Company will be 32,531,416 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Transparency Rules.

For further information please contact

Artemis Fund Managers Limited +44 (0)131 225 7300

Billy Aitken

J.P. Morgan Cazenove (Corporate Broker) +44 (0)20 7742 4000

William Simmonds

Anne Ross

Oliver Kenyon

 

Defined terms used in this announcement have the same meanings given in the Prospectus unless the context otherwise requires.

This announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by, J.P. Morgan Cazenove or by any of its respective affiliates or agents as to or in relation to the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or their advisers and any liability therefore is expressly disclaimed.

J.P. Morgan Securities plc, which conducts its UK investment banking activities as J.P. Morgan Cazenove, is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority, and is acting exclusively for the Company and no-one else in connection with the matters described in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to clients of J.P. Morgan Cazenove nor for providing advice in connection with the Placing and the contents of this announcement or any other matter referred to herein.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBLGDLXBGBGRL
Date   Source Headline
4th Jul 20235:06 pmPRNTransaction in Own Shares
4th Jul 202310:36 amPRNNet Asset Value(s)
3rd Jul 20235:22 pmPRNTransaction in Own Shares
3rd Jul 202311:42 amPRNNet Asset Value(s)
3rd Jul 20238:38 amPRNCompliance with Market Abuse Regulation
30th Jun 20235:14 pmPRNTotal Voting Rights
30th Jun 20235:07 pmPRNTransaction in Own Shares
30th Jun 202311:23 amPRNNet Asset Value(s)
29th Jun 20235:06 pmPRNTransaction in Own Shares
29th Jun 202310:53 amPRNNet Asset Value(s)
28th Jun 20235:24 pmPRNTransaction in Own Shares
28th Jun 202311:05 amPRNNet Asset Value(s)
27th Jun 20235:15 pmPRNTransaction in Own Shares
27th Jun 20233:43 pmPRNDirector/PDMR Shareholding
27th Jun 202310:54 amPRNNet Asset Value(s)
27th Jun 20237:00 amPRNChange of Investment Management Arrangements
26th Jun 20235:09 pmPRNTransaction in Own Shares
26th Jun 202310:57 amPRNNet Asset Value(s)
26th Jun 20237:00 amPRNTransaction in Own Shares
23rd Jun 202310:34 amPRNNet Asset Value(s)
22nd Jun 20235:01 pmPRNTransaction in Own Shares
22nd Jun 202311:14 amPRNNet Asset Value(s)
21st Jun 20235:20 pmPRNTransaction in Own Shares
21st Jun 202311:38 amPRNNet Asset Value(s)
28th Apr 20235:30 pmPRNTotal Voting Rights
28th Apr 20235:14 pmPRNTransaction in Own Shares
28th Apr 202311:50 amPRNNet Asset Value(s)
6th Mar 202311:59 amRNSNet Asset Value(s)
3rd Mar 20235:58 pmRNSTransaction in Own Shares
3rd Mar 202312:29 pmRNSNet Asset Value(s)
2nd Mar 20235:13 pmRNSTransaction in Own Shares
2nd Mar 202311:52 amRNSNet Asset Value(s)
1st Mar 20235:24 pmRNSTransaction in Own Shares
1st Mar 20231:10 pmRNSNet Asset Value(s)
1st Mar 202311:19 amRNSTotal Voting Rights
1st Mar 20237:00 amRNSHalf-Yearly Financial Report
28th Feb 20236:20 pmRNSTransaction in Own Shares
28th Feb 202312:25 pmRNSNet Asset Value(s)
27th Feb 20235:52 pmRNSTransaction in Own Shares
27th Feb 202312:06 pmRNSNet Asset Value(s)
24th Feb 20235:48 pmRNSTransaction in Own Shares
24th Feb 202312:22 pmRNSNet Asset Value(s)
24th Feb 202311:44 amRNSManagement changes
23rd Feb 202311:26 amRNSNet Asset Value(s)
22nd Feb 202311:55 amRNSNet Asset Value(s)
21st Feb 202311:58 amRNSNet Asset Value(s)
20th Feb 202311:40 amRNSNet Asset Value(s)
17th Feb 202312:08 pmRNSNet Asset Value(s)
16th Feb 202312:30 pmRNSNet Asset Value(s)
15th Feb 202312:04 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.